Showing posts with label GSK. Show all posts
Showing posts with label GSK. Show all posts

November 6, 2021

Notable Analyst Upgrades and Downgrades for Week of November 1 2021 (Part 2)

 



Upgrades:

 


Phillips 66 (NYSE:PSX) was upgraded by investment analysts at The Goldman Sachs Group from a “buy” rating to a “conviction-buy” rating in a research note issued on Wednesday, The Fly reports.

Several other equities research analysts also recently issued reports on PSX. Piper Sandler upgraded Phillips 66 from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $85.00 to $87.00 in a report on Wednesday, October 6th. Citigroup boosted their price target on Phillips 66 from $75.00 to $80.00 and gave the company a “neutral” rating in a report on Wednesday, October 6th. Royal Bank of Canada boosted their price target on Phillips 66 from $94.00 to $95.00 and gave the company an “outperform” rating in a report on Tuesday. Barclays lowered their price target on Phillips 66 from $95.00 to $88.00 and set an “overweight” rating for the company in a report on Thursday, July 8th. Finally, Morgan Stanley boosted their price target on Phillips 66 from $90.00 to $95.00 and gave the company an “equal weight” rating in a report on Monday. Five investment analysts have rated the stock with a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Phillips 66 currently has an average rating of “Buy” and an average target price of $85.63. Read more …

 


Thomson Reuters (NYSE:TRI) (TSE:TRI) was upgraded by investment analysts at BNP Paribas from an “underperform” rating to a “neutral” rating in a note issued to investors on Wednesday, Price Targets.com reports.

Several other brokerages also recently weighed in on TRI. TD Securities upgraded Thomson Reuters from a “hold” rating to a “buy” rating and set a $160.00 price target for the company in a report on Wednesday, October 6th. Zacks Investment Research upgraded Thomson Reuters from a “hold” rating to a “buy” rating and set a $123.00 price target for the company in a report on Thursday, October 7th. Royal Bank of Canada downgraded Thomson Reuters from an “outperform” rating to a “sector perform” rating and boosted their price target for the company from $118.00 to $122.00 in a report on Monday. Morgan Stanley boosted their price objective on shares of Thomson Reuters from $105.00 to $106.00 and gave the company an “equal weight” rating in a research note on Thursday, September 23rd. Finally, National Bank Financial boosted their price objective on shares of Thomson Reuters from C$145.00 to C$162.00 and gave the company a “sector perform” rating in a research note on Thursday, September 2nd. Seven investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $125.90. Read more …

 


QUALCOMM (NASDAQ:QCOM) was upgraded by research analysts at The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a research note issued to investors on Thursday, The Fly reports.

A number of other research analysts also recently issued reports on the company. Canaccord Genuity reissued a “buy” rating and issued a $225.00 price objective (up from $200.00) on shares of QUALCOMM in a research note on Thursday, August 12th. Cowen boosted their target price on QUALCOMM from $180.00 to $185.00 and gave the company an “outperform” rating in a research report on Thursday, July 29th. Susquehanna reaffirmed a “hold” rating and issued a $157.00 target price on shares of QUALCOMM in a research report on Thursday, July 29th. Zacks Investment Research lowered QUALCOMM from a “buy” rating to a “hold” rating and set a $135.00 target price for the company. in a research report on Monday, October 4th. Finally, Mizuho decreased their target price on QUALCOMM from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Tuesday, October 19th. Thirteen equities research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $166.77. Read more…

 

 


GlaxoSmithKline (NYSE:GSK) was upgraded by stock analysts at Barclays from an "underweight" rating to an "equal weight" rating in a research note issued on Friday, The Fly reports.

GSK has been the topic of several other research reports. Morgan Stanley reaffirmed an "equal weight" rating on shares of GlaxoSmithKline in a report on Wednesday. JPMorgan Chase & Co. reaffirmed a "neutral" rating on shares of GlaxoSmithKline in a report on Monday. Berenberg Bank reaffirmed a "buy" rating on shares of GlaxoSmithKline in a report on Monday, October 18th. Zacks Investment Research downgraded shares of GlaxoSmithKline from a "hold" rating to a "sell" rating and set a $41.00 target price on the stock. in a report on Tuesday, July 20th. Finally, UBS Group reaffirmed a "neutral" rating on shares of GlaxoSmithKline in a report on Monday, September 20th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $41.00.

GlaxoSmithKline stock opened at $43.00 on Friday. The company has a debt-to-equity ratio of -0.95, a current ratio of 0.81 and a quick ratio of 0.54. The business has a 50 day simple moving average of $39.81 and a 200-day simple moving average of $39.66. GlaxoSmithKline has a 12 month low of $33.53 and a 12 month high of $43.61. The stock has a market capitalization of $115.78 billion, a PE ratio of 18.22, a price-to-earnings-growth ratio of 2.57 and a beta of 0.72. Read more …

June 25, 2021

Notable Analyst Upgrades and Downgrades for Week of June 21, 2021

 



Upgrades:

 


Eastman Chemical (NYSE:EMN) was upgraded by analysts at Scotiabank from a “sector perform” rating to a “sector outperform” rating in a research note issued to investors on Monday, The Fly reports. The firm presently has a $145.00 target price on the basic materials company’s stock. Scotiabank’s price objective indicates a potential upside of 27.03% from the stock’s current price.

Other analysts also recently issued research reports about the stock. KeyCorp lifted their price target on shares of Eastman Chemical from $126.00 to $135.00 and gave the company an “overweight” rating in a research note on Monday, May 3rd. The Goldman Sachs Group raised shares of Eastman Chemical from a “neutral” rating to a “buy” rating and set a $148.00 price objective for the company in a research note on Tuesday, May 11th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Eastman Chemical from $132.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, June 14th. Wolfe Research assumed coverage on Eastman Chemical in a research report on Wednesday, June 9th. They set an “outperform” rating on the stock. Finally, Tudor Pickering downgraded Eastman Chemical from a “buy” rating to a “hold” rating and set a $117.00 price target on the stock. in a research report on Monday, May 3rd. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $110.31. Read more …

 


Accenture (NYSE:ACN) was upgraded by stock analysts at Exane BNP Paribas from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports.

A number of other research firms have also issued reports on ACN. Barclays lifted their target price on Accenture from $300.00 to $310.00 and gave the company an “overweight” rating in a report on Monday, March 22nd. BMO Capital Markets lifted their target price on Accenture from $292.00 to $302.00 and gave the company a “market perform” rating in a report on Friday, March 19th. They noted that the move was a valuation call. Susquehanna lifted their target price on Accenture from $290.00 to $325.00 and gave the company a “positive” rating in a report on Friday, March 19th. Societe Generale lifted their target price on Accenture from $313.00 to $329.00 and gave the company a “buy” rating in a report on Tuesday, June 15th. Finally, Royal Bank of Canada lifted their target price on Accenture from $278.00 to $301.00 in a report on Friday, March 19th. Six analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Accenture presently has a consensus rating of “Buy” and a consensus target price of $288.52. Read more …

 


Welltower (NYSE:WELL) was upgraded by analysts at Scotiabank from a “sector underperform” rating to a “sector perform” rating in a report released on Wednesday, Analyst Price Targets reports. The brokerage currently has a $83.00 price target on the real estate investment trust’s stock, up from their prior price target of $68.00. Scotiabank’s price objective points to a potential upside of 0.95% from the company’s previous close.

A number of other brokerages also recently commented on WELL. Morgan Stanley raised their price objective on Welltower from $76.00 to $79.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 7th. Deutsche Bank Aktiengesellschaft raised their target price on Welltower from $76.00 to $80.00 and gave the stock a “buy” rating in a research report on Thursday, June 3rd. Evercore ISI upgraded Welltower from an “in-line” rating to an “outperform” rating and raised their target price for the stock from $77.00 to $86.00 in a research report on Monday, June 14th. Mizuho raised their target price on Welltower from $60.00 to $70.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 28th. Finally, Raymond James upgraded Welltower from a “market perform” rating to a “strong-buy” rating and set a $92.00 target price for the company in a research report on Tuesday, June 15th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $73.59. Read more …

 

 


Magna International (NYSE:MGA) (TSE:MG) was upgraded by investment analysts at The Goldman Sachs Group from a "neutral" rating to a "buy" rating in a research note issued on Wednesday, The Fly reports.

Several other analysts also recently issued reports on MGA. Morgan Stanley raised Magna International from an "underweight" rating to an "equal weight" rating and lifted their price target for the company from $61.00 to $96.00 in a research note on Wednesday, April 14th. BMO Capital Markets lifted their price target on Magna International from $108.00 to $115.00 and gave the company an "outperform" rating in a research note on Monday, May 31st. Wells Fargo & Company initiated coverage on Magna International in a research note on Wednesday, March 31st. They issued an "equal weight" rating and a $96.00 price target on the stock. Zacks Investment Research downgraded Magna International from a "strong-buy" rating to a "hold" rating and set a $100.00 price target on the stock. in a research note on Friday, April 23rd. Finally, Barclays raised Magna International from an "equal weight" rating to an "overweight" rating in a research note on Thursday, April 15th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The stock presently has a consensus rating of "Buy" and a consensus target price of $89.47. Read more …

March 26, 2021

Notable Analyst Upgrades and Downgrades for Week of March 22, 2021

 


Upgrades:

 


Kansas City Southern (NYSE:KSU) was upgraded by equities researchers at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued to investors on Monday, Briefing.com reports. The firm presently has a $275.00 price objective on the transportation company’s stock. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 22.68% from the company’s previous close.

A number of other brokerages have also weighed in on KSU. Morgan Stanley raised their price objective on Kansas City Southern from $142.00 to $200.00 and gave the company a “positive” rating in a research note on Monday, January 25th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised their price target on shares of Kansas City Southern from $220.00 to $250.00 in a research report on Monday, January 11th. Smith Barney Citigroup upped their price target on shares of Kansas City Southern from $220.00 to $250.00 in a report on Monday, January 11th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Kansas City Southern from $197.00 to $212.00 and gave the company a “hold” rating in a research note on Thursday, January 28th. Finally, BMO Capital Markets boosted their target price on shares of Kansas City Southern from $215.00 to $240.00 and gave the stock an “outperform” rating in a research report on Monday, January 25th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $208.10. Read more …

 


Dollar General (NYSE:DG) was upgraded by research analysts at Atlantic Securities from a “neutral” rating to an “overweight” rating in a research note issued on Monday, Benzinga reports. The brokerage presently has a $243.00 price target on the stock. Atlantic Securities’ price target would suggest a potential upside of 29.41% from the stock’s previous close.

A number of other equities research analysts have also commented on DG. Deutsche Bank Aktiengesellschaft upgraded Dollar General from a “hold” rating to a “buy” rating and increased their price target for the stock from $214.00 to $241.00 in a research report on Tuesday, February 9th. Smith Barney Citigroup increased their price target on Dollar General from $235.00 to $250.00 in a research report on Friday, December 4th. KeyCorp decreased their price target on Dollar General from $235.00 to $220.00 and set an “overweight” rating on the stock in a research report on Friday. Royal Bank of Canada decreased their price objective on Dollar General from $239.00 to $206.00 and set an “outperform” rating on the stock in a research report on Friday. Finally, Morgan Stanley increased their price objective on Dollar General from $240.00 to $245.00 and gave the company an “overweight” rating in a research report on Monday, December 7th. Three research analysts have rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. Dollar General presently has a consensus rating of “Buy” and a consensus price target of $228.16. Read more …

 


PepsiCo (NASDAQ:PEP) was upgraded by Barclays from an “equal weight” rating to an “overweight” rating in a note issued to investors on Monday, Briefing.com reports. The firm presently has a $151.00 price objective on the stock. Barclays‘s price objective would suggest a potential upside of 12.27% from the stock’s current price.

PEP has been the subject of a number of other reports. Deutsche Bank Aktiengesellschaft raised their price target on shares of PepsiCo from $143.00 to $148.00 and gave the stock a “hold” rating in a report on Wednesday, February 3rd. Wells Fargo & Company assumed coverage on shares of PepsiCo in a report on Monday, December 7th. They set an “equal weight” rating and a $157.00 price objective on the stock. Sanford C. Bernstein assumed coverage on shares of PepsiCo in a report on Tuesday, January 19th. They set an “underperform” rating and a $136.00 price objective for the company. Zacks Investment Research upgraded PepsiCo from a “hold” rating to a “buy” rating and set a $142.00 target price on the stock in a report on Friday, February 12th. Finally, Royal Bank of Canada cut shares of PepsiCo from an “outperform” rating to a “sector perform” rating and set a $153.00 price target on the stock. in a report on Monday, January 4th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, five have issued a hold rating, eight have given a buy rating and two have given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $146.53. Read more …

 

 


Texas Instruments (NASDAQ:TXN) was upgraded by equities researchers at Longbow Research from a "neutral" rating to a "buy" rating in a research note issued to investors on Tuesday, Briefing.com reports.

TXN has been the topic of a number of other research reports. Summit Insights upgraded Texas Instruments from a "hold" rating to a "buy" rating in a research report on Wednesday, January 27th. Jefferies Financial Group lifted their price target on Texas Instruments from $185.00 to $206.00 and gave the stock a "buy" rating in a research report on Wednesday, January 27th. Barclays boosted their price objective on Texas Instruments from $140.00 to $155.00 and gave the company an "underweight" rating in a research note on Tuesday, January 26th. They noted that the move was a valuation call. Royal Bank of Canada raised their target price on shares of Texas Instruments from $155.00 to $180.00 and gave the stock a "sector perform" rating in a research report on Wednesday, January 27th. Finally, Rosenblatt Securities upped their price target on shares of Texas Instruments from $175.00 to $200.00 and gave the company a "buy" rating in a research report on Wednesday, January 27th. Four investment analysts have rated the stock with a sell rating, nine have issued a hold rating and fifteen have given a buy rating to the company's stock. The stock presently has an average rating of "Hold" and a consensus target price of $167.78. Read more …

January 23, 2021

Notable Analyst Upgrades and Downgrades for Week of January 18, 2021


 

Upgrades:

 


Digital Realty Trust (NYSE:DLR) was upgraded by research analysts at Raymond James from an “outperform” rating to a “strong-buy” rating in a research report issued on Tuesday, Anlyst Ratings reports. The firm currently has a $175.00 target price on the real estate investment trust’s stock. Raymond James’ target price suggests a potential upside of 26.86% from the company’s current price.

Several other research firms have also commented on DLR. Morgan Stanley raised their price objective on shares of Digital Realty Trust from $141.00 to $148.00 and gave the company an “equal weight” rating in a research note on Tuesday, September 29th. Edward Jones upgraded shares of Digital Realty Trust from a “hold” rating to a “buy” rating in a report on Friday, December 18th. Credit Suisse Group increased their target price on shares of Digital Realty Trust from $173.00 to $179.00 and gave the stock an “outperform” rating in a report on Friday, October 30th. TD Securities upgraded shares of Digital Realty Trust from a “hold” rating to a “buy” rating and set a $170.00 target price on the stock in a report on Friday, December 18th. Finally, TheStreet lowered shares of Digital Realty Trust from a “b-” rating to a “c+” rating in a report on Tuesday, December 1st. Five research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Digital Realty Trust has a consensus rating of “Buy” and an average target price of $160.40. Read more …

 


Illinois Tool Works (NYSE:ITW) was upgraded by The Goldman Sachs Group from a "sell" rating to a "neutral" rating in a research note issued on Tuesday, The Fly reports.

Other equities analysts have also issued research reports about the stock. Bank of America raised shares of Illinois Tool Works from an "underperform" rating to a "neutral" rating and boosted their price target for the company from $175.00 to $212.00 in a report on Thursday, October 29th. Credit Suisse Group raised shares of Illinois Tool Works from a "neutral" rating to an "outperform" rating and boosted their price target for the company from $209.00 to $235.00 in a report on Tuesday, January 12th. BMO Capital Markets boosted their price target on shares of Illinois Tool Works from $205.00 to $225.00 in a report on Monday, October 26th. Wells Fargo & Company boosted their price target on shares of Illinois Tool Works from $220.00 to $225.00 and gave the company an "overweight" rating in a report on Monday, October 26th. Finally, Barclays boosted their price target on shares of Illinois Tool Works from $200.00 to $207.00 and gave the company an "equal weight" rating in a report on Tuesday, January 5th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating to the company. Illinois Tool Works has a consensus rating of "Hold" and an average price target of $195.24. Read more …

 


Emerson Electric (NYSE:EMR) was upgraded by The Goldman Sachs Group from a “neutral” rating to a “buy” rating in a note issued to investors on Tuesday, Analyst Ratings Network reports. The firm presently has a $97.00 target price on the industrial products company’s stock, up from their prior target price of $89.00. The Goldman Sachs Group’s target price indicates a potential upside of 15.77% from the company’s previous close.

Other research analysts also recently issued reports about the company. UBS Group upgraded Emerson Electric from a “neutral” rating to a “buy” rating and boosted their price target for the company from $69.00 to $100.00 in a report on Friday. JPMorgan Chase & Co. boosted their price target on Emerson Electric from $80.00 to $85.00 and gave the company an “overweight” rating in a report on Wednesday, October 7th. Cowen reiterated a “buy” rating on shares of Emerson Electric in a report on Sunday, October 4th. Stephens began coverage on Emerson Electric in a report on Thursday, October 15th. They issued an “overweight” rating for the company. Finally, Credit Suisse Group boosted their price objective on shares of Emerson Electric from $77.00 to $79.00 and gave the company an “outperform” rating in a research note on Wednesday, November 4th. Five research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Emerson Electric presently has an average rating of “Buy” and an average price target of $76.31. Read more …

 

 


American Express (NYSE:AXP) was upgraded by stock analysts at JPMorgan Chase & Co. from an "underweight" rating to an "overweight" rating in a report issued on Tuesday, AnalystRatings.net reports. The firm presently has a $148.00 price target on the payment services company's stock. JPMorgan Chase & Co.'s price target would suggest a potential upside of 16.72% from the company's current price.

AXP has been the subject of several other research reports. DZ Bank cut shares of American Express from a "buy" rating to a "hold" rating and set a $128.00 target price for the company. in a research report on Wednesday, December 9th. 140166 cut shares of American Express from a "positive" rating to a "neutral" rating and set a $110.00 target price for the company. in a research report on Friday, October 9th. Barclays upgraded shares of American Express from an "equal weight" rating to a "positive" rating and upped their target price for the stock from $114.00 to $132.00 in a research report on Thursday, December 10th. They noted that the move was a valuation call. Bank of America cut shares of American Express from a "neutral" rating to an "underperform" rating and decreased their price objective for the company from $106.00 to $95.00 in a report on Wednesday, September 23rd. Finally, Zacks Investment Research cut shares of American Express from a "hold" rating to a "sell" rating and set a $126.00 price objective for the company. in a report on Wednesday, November 25th. Three investment analysts have rated the stock with a sell rating, twelve have given a hold rating and twelve have assigned a buy rating to the company. The stock presently has a consensus rating of "Hold" and an average target price of $117.46. Read more …

 

December 4, 2020

Notable Analyst Upgrades and Downgrades for Week of November 30, 2020 (Part 2)

 


Upgrades:

  


The Charles Schwab (NYSE:SCHW) was upgraded by investment analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating in a note issued to investors on Tuesday, The Fly reports. The firm currently has a $58.00 price objective on the financial services provider's stock, up from their prior price objective of $44.00. Wells Fargo & Company's price objective suggests a potential upside of 18.90% from the stock's current price.

A number of other analysts have also recently commented on SCHW. Bank of America boosted their price objective on The Charles Schwab from $40.00 to $42.00 and gave the company a "neutral" rating in a research report on Friday, October 16th. TheStreet raised shares of The Charles Schwab from a "c" rating to a "b-" rating in a research note on Thursday, October 8th. Raymond James reissued a "hold" rating on shares of The Charles Schwab in a research note on Thursday, August 6th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised shares of The Charles Schwab from a "neutral" rating to a "buy" rating and raised their price target for the stock from $44.00 to $54.00 in a research note on Tuesday, November 17th. Finally, Credit Suisse Group raised their price target on shares of The Charles Schwab from $41.00 to $43.00 and gave the stock a "neutral" rating in a research note on Tuesday, November 3rd. Eight research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company has a consensus rating of "Hold" and an average price target of $47.53. Read more …

 


The Southern (NYSE:SO) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating in a research report issued to clients and investors on Tuesday, The Fly reports.

Several other equities analysts have also recently commented on the stock. UBS Group dropped their target price on shares of The Southern from $57.00 to $55.00 and set a “neutral” rating for the company in a research report on Tuesday, September 1st. Barclays boosted their target price on shares of The Southern from $61.00 to $73.00 and gave the company an “overweight” rating in a research report on Wednesday, November 18th. KeyCorp boosted their target price on shares of The Southern from $65.00 to $66.00 and gave the company an “overweight” rating in a research report on Monday, October 19th. Morgan Stanley boosted their target price on shares of The Southern from $60.00 to $62.00 and gave the company an “underweight” rating in a research report on Tuesday, November 17th. Finally, BMO Capital Markets began coverage on shares of The Southern in a research report on Tuesday, November 24th. They issued a “market perform” rating and a $67.00 target price for the company. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average target price of $63.66. Read more …

 


FedEx (NYSE:FDX)‘s stock had its “buy” rating reaffirmed by analysts at Sanford C. Bernstein in a research report issued on Wednesday, AnalystRatings.net reports. They currently have a $308.00 price objective on the shipping service provider’s stock. Sanford C. Bernstein’s price target suggests a potential upside of 5.25% from the company’s current price.

Several other brokerages have also recently weighed in on FDX. TheStreet raised FedEx from a “c+” rating to a “b” rating in a report on Tuesday, September 15th. Wells Fargo & Company boosted their price target on shares of FedEx from $221.00 to $286.00 and gave the stock an “overweight” rating in a research note on Wednesday, September 16th. Berenberg Bank reaffirmed a “buy” rating and issued a $320.00 price objective on shares of FedEx in a research note on Tuesday, October 27th. Deutsche Bank Aktiengesellschaft upgraded shares of FedEx from a “hold” rating to a “buy” rating and upped their target price for the company from $243.00 to $318.00 in a research report on Monday, September 28th. Finally, JPMorgan Chase & Co. reaffirmed a “buy” rating and set a $298.00 price objective (up from $265.00) on shares of FedEx in a research note on Wednesday, September 16th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $287.48. Read more …

 

 


S&P Global (NYSE:SPGI) was upgraded by equities researchers at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating in a research note issued on Wednesday, The Fly reports.

SPGI has been the topic of a number of other reports. Stifel Nicolaus increased their price objective on S&P Global from $351.00 to $353.00 and gave the company a "hold" rating in a report on Friday, October 2nd. UBS Group increased their price objective on S&P Global from $418.00 to $422.00 and gave the company a "buy" rating in a report on Tuesday, October 6th. Deutsche Bank Aktiengesellschaft started coverage on S&P Global in a report on Monday. They issued a "buy" rating and a $415.00 price objective on the stock. BMO Capital Markets cut their price objective on S&P Global from $375.00 to $392.00 in a report on Wednesday, October 28th. Finally, Morgan Stanley upped their target price on S&P Global from $404.00 to $411.00 and gave the stock an "overweight" rating in a research note on Wednesday, October 28th. Three equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. S&P Global has an average rating of "Buy" and an average target price of $366.64. Read more …

 

November 13, 2020

Notable Analyst Upgrades and Downgrades for Week of November 9, 2020

 


Upgrades:

 


C.H. Robinson Worldwide (NASDAQ:CHRW) was upgraded by research analysts at Smith Barney Citigroup from a "neutral" rating to a "buy" rating in a research report issued to clients and investors on Monday, The Fly reports. The brokerage presently has a $118.00 target price on the transportation company's stock, up from their prior target price of $100.00. Smith Barney Citigroup's target price indicates a potential upside of 26.00% from the company's previous close.

CHRW has been the subject of a number of other reports. Barclays raised C.H. Robinson Worldwide from a "neutral" rating to an "overweight" rating and boosted their price objective for the stock from $95.00 to $115.00 in a research report on Friday, October 16th. Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised C.H. Robinson Worldwide from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $100.00 to $118.00 in a research report on Monday. Stifel Nicolaus downgraded C.H. Robinson Worldwide from a "buy" rating to a "hold" rating and boosted their price objective for the stock from $79.00 to $94.00 in a research report on Thursday, July 30th. They noted that the move was a valuation call. Stephens downgraded C.H. Robinson Worldwide from an "overweight" rating to an "equal weight" rating and lowered their price objective for the stock from $110.00 to $95.00 in a research report on Thursday, October 29th. Finally, Loop Capital downgraded C.H. Robinson Worldwide from a "buy" rating to a "hold" rating and set a $96.00 price objective for the company. in a research report on Thursday, July 30th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of "Hold" and a consensus target price of $90.67. Read more …

 


Albemarle (NYSE:ALB) was upgraded by equities research analysts at Smith Barney Citigroup from a “neutral” rating to a “buy” rating in a research report issued to clients and investors on Monday, The Fly reports. The firm presently has a $132.00 price objective on the specialty chemicals company’s stock, up from their prior price objective of $99.00. Smith Barney Citigroup’s target price would suggest a potential upside of 13.53% from the company’s current price.

Several other brokerages also recently weighed in on ALB. KeyCorp increased their target price on shares of Albemarle from $60.00 to $89.00 and gave the company an “underweight” rating in a research note on Friday. Berenberg Bank downgraded shares of Albemarle from a “hold” rating to a “sell” rating and increased their target price for the company from $65.00 to $68.00 in a research note on Monday, July 27th. Jefferies Financial Group increased their target price on shares of Albemarle from $81.00 to $100.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. BMO Capital Markets raised their price target on shares of Albemarle from $115.00 to $120.00 and gave the stock an “outperform” rating in a research note on Friday. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell raised shares of Albemarle from a “neutral” rating to a “buy” rating and raised their price target for the stock from $99.00 to $132.00 in a research note on Monday. Six research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $92.54. Read more …

 


Ventas (NYSE:VTR) was upgraded by stock analysts at Jefferies Financial Group from an “underperform” rating to a “hold” rating in a note issued to investors on Tuesday, Briefing.com reports. The brokerage presently has a $50.00 price target on the real estate investment trust’s stock. Jefferies Financial Group’s target price points to a potential upside of 6.72% from the company’s current price.

Several other equities analysts have also recently issued reports on the stock. Morgan Stanley upped their target price on shares of Ventas from $36.00 to $39.00 and gave the company an “equal weight” rating in a research note on Thursday, September 17th. Royal Bank of Canada upgraded shares of Ventas from a “sector perform” rating to an “outperform” rating and upped their target price for the company from $34.00 to $45.00 in a research note on Friday, August 14th. Barclays upped their target price on shares of Ventas from $37.00 to $42.00 and gave the company an “equal weight” rating in a research note on Wednesday, September 16th. Argus cut shares of Ventas from a “buy” rating to a “hold” rating in a research note on Tuesday, September 8th. Finally, Stifel Nicolaus restated a “hold” rating and set a $43.00 target price on shares of Ventas in a research note on Tuesday, September 1st. Five investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $39.31. Read more …

 

 


Chubb (NYSE:CB) was upgraded by The Goldman Sachs Group from a “sell” rating to a “buy” rating in a research note issued on Tuesday, Briefing.com reports. The brokerage presently has a $163.00 price target on the financial services provider’s stock, up from their previous price target of $120.00. The Goldman Sachs Group’s price objective would suggest a potential upside of 10.90% from the company’s current price.

Several other research firms also recently weighed in on CB. William Blair upgraded Chubb from an “underperform” rating to a “market perform” rating in a research report on Monday, July 20th. Bank of America upgraded Chubb from an “underperform” rating to a “neutral” rating and lifted their price objective for the company from $123.00 to $132.00 in a report on Thursday, October 29th. They noted that the move was a valuation call. Zacks Investment Research downgraded Chubb from a “hold” rating to a “strong sell” rating and set a $97.00 price objective for the company. in a report on Wednesday, September 30th. JPMorgan Chase & Co. upgraded Chubb from a “neutral” rating to an “overweight” rating and set a $152.00 price objective for the company in a report on Monday, October 12th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Chubb from $135.00 to $136.00 and gave the company a “hold” rating in a report on Thursday, October 29th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and ten have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $145.31. Read more …

 

November 6, 2020

Notable Analyst Upgrades and Downgrades for Week of November 2, 2020

 


Upgrades:

 


Cardinal Health (NYSE:CAH) was upgraded by investment analysts at Barclays from an “equal weight” rating to an “overweight” rating in a note issued to investors on Monday, Anlyst Ratings reports. The brokerage presently has a $57.00 price target on the stock. Barclays‘s price objective suggests a potential upside of 24.48% from the company’s current price.

Other research analysts have also issued reports about the company. Morgan Stanley upped their price objective on Cardinal Health from $59.00 to $61.00 and gave the company an “equal weight” rating in a report on Friday, August 7th. UBS Group reduced their target price on Cardinal Health from $65.00 to $64.00 and set a “buy” rating on the stock in a report on Monday, August 10th. Bank of America increased their target price on Cardinal Health from $61.00 to $63.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Guggenheim raised Cardinal Health from a “neutral” rating to a “buy” rating in a report on Monday, July 20th. Finally, Zacks Investment Research raised Cardinal Health from a “hold” rating to a “buy” rating and set a $48.00 target price on the stock in a report on Thursday. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $58.90. Read more …

 


McKesson (NYSE:MCK) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a research report issued on Monday, AnalystRatings.net reports. The firm currently has a $166.00 price objective on the stock. Barclays‘s price objective would indicate a potential upside of 12.55% from the stock’s previous close.

Several other equities research analysts have also commented on the stock. ValuEngine upgraded shares of McKesson from a “strong sell” rating to a “sell” rating in a research note on Monday, October 19th. Zacks Investment Research downgraded shares of McKesson from a “hold” rating to a “sell” rating and set a $161.00 price objective on the stock. in a research report on Thursday, July 16th. Credit Suisse Group raised their price objective on shares of McKesson from $160.00 to $162.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. JPMorgan Chase & Co. raised their price objective on shares of McKesson from $187.00 to $198.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 4th. Finally, Guggenheim raised their price objective on shares of McKesson from $168.00 to $175.00 and gave the stock a “buy” rating in a research report on Wednesday, July 8th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $178.00. Read more …

 


GlaxoSmithKline (NYSE:GSK) was upgraded by Liberum Capital from a “hold” rating to a “buy” rating in a research note issued to investors on Monday, The Fly reports.

Several other brokerages also recently issued reports on GSK. Societe Generale reiterated a “buy” rating on shares of GlaxoSmithKline in a research report on Friday, September 18th. Berenberg Bank began coverage on GlaxoSmithKline in a research note on Tuesday, September 29th. They issued a “buy” rating for the company. AlphaValue raised shares of GlaxoSmithKline to a “buy” rating in a report on Tuesday, September 1st. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of GlaxoSmithKline in a research report on Wednesday, October 21st. Finally, Morgan Stanley reaffirmed an “underweight” rating on shares of GlaxoSmithKline in a research note on Friday, October 9th. Four equities research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $41.00. Read more …

 

 

 


Intel (NASDAQ:INTC) was upgraded by stock analysts at The Goldman Sachs Group from a “sell” rating to a “neutral” rating in a research note issued to investors on Wednesday, The Fly reports. The firm presently has a $38.00 target price on the chip maker’s stock, down from their prior target price of $46.00. The Goldman Sachs Group’s price target would indicate a potential downside of 16.04% from the company’s previous close.

Several other equities analysts also recently commented on the stock. Needham & Company LLC reissued a “hold” rating on shares of Intel in a research report on Tuesday, July 7th. Bank of America downgraded shares of Intel from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $60.00 to $45.00 in a research report on Friday, October 23rd. SVB Leerink initiated coverage on shares of Intel in a research report on Friday, July 24th. They set a “hold” rating on the stock. Northland Securities raised shares of Intel from an “under perform” rating to a “market perform” rating and set a $46.00 target price on the stock in a research report on Monday. Finally, Roth Capital lowered their target price on shares of Intel from $55.00 to $50.00 and set a “neutral” rating on the stock in a research report on Friday, October 23rd. Eleven analysts have rated the stock with a sell rating, eighteen have issued a hold rating and sixteen have assigned a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $57.69. Read more …

 

February 22, 2019

Notable Analyst Upgrades and Downgrades for Week of February 18, 2019



Upgrades:


Freeport-McMoRan (NYSE:FCX) was upgraded by equities research analysts at Citigroup from a “neutral” rating to a “buy” rating in a report released on Tuesday, The Fly reports. Several other equities analysts have also commented on FCX. Raymond James set a $16.00 price target on Freeport-McMoRan and gave the stock a “hold” rating in a research report on Wednesday, October 24th. ValuEngine lowered Freeport-McMoRan from a “sell” rating to a “strong sell” rating in a research report on Wednesday, October 24th. BMO Capital Markets set a $13.00 price target on Freeport-McMoRan and gave the stock a “hold” rating in a research report on Thursday, October 25th. B. Riley cut their target price on Freeport-McMoRan from $18.00 to $16.00 and set a “buy” rating on the stock in a research report on Thursday, October 25th. Finally, Royal Bank of Canada lowered Freeport-McMoRan from a “sector perform” rating to an “underperform” rating and set a $12.20 target price on the stock. in a research report on Tuesday, November 6th. They noted that the move was a valuation call. Three research analysts have rated the stock with a sell rating, eleven have issued a hold rating and seven have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $16.15. Read more …

Macquarie upgraded shares of PepsiCo (NASDAQ:PEP) from a neutral rating to an outperform rating in a report published on Tuesday, MarketBeat reports. The brokerage currently has $126.00 price target on the stock. PEP has been the subject of a number of other reports. BidaskClub raised shares of PepsiCo from a hold rating to a buy rating in a research note on Friday, October 26th. Zacks Investment Research reaffirmed a sell rating on shares of PepsiCo in a research note on Wednesday, November 14th. Jefferies Financial Group upped their price objective on shares of PepsiCo to $119.00 and gave the company a hold rating in a research note on Tuesday. They noted that the move was a valuation call. Finally, UBS Group initiated coverage on shares of PepsiCo in a research note on Thursday, December 13th. They set a neutral rating and a $123.00 price objective for the company. One analyst has rated the stock with a sell rating, thirteen have given a hold rating and six have given a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of $119.83. Read more …

Intel (NASDAQ:INTC) was upgraded by research analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research note issued on Friday, The Fly reports. The brokerage presently has a $64.00 price objective on the chip maker’s stock, up from their prior price objective of $55.00. Morgan Stanley’s target price indicates a potential upside of 21.77% from the stock’s previous close. Several other research analysts have also recently weighed in on INTC. BidaskClub cut shares of Intel from a “buy” rating to a “hold” rating in a research note on Thursday, January 17th. Royal Bank of Canada reiterated a “neutral” rating and set a $55.00 price target on shares of Intel in a research note on Wednesday, January 23rd. Nomura reiterated a “buy” rating and set a $55.00 price target on shares of Intel in a research note on Wednesday, November 7th. Citigroup reiterated a “buy” rating and set a $54.00 price target (up previously from $50.00) on shares of Intel in a research note on Friday, January 11th. Finally, Goldman Sachs Group reiterated a “sell” rating and set a $44.00 price target on shares of Intel in a research note on Tuesday, January 8th. Six analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and nineteen have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $53.65. Read more …




Downgrades:


Norfolk Southern (NYSE:NSC) was downgraded by investment analysts at Royal Bank of Canada from a “sector perform” rating to an “underperform” rating in a report released on Tuesday, Marketbeat reports. They currently have a $178.00 price target on the railroad operator’s stock, down from their prior price target of $180.00. Royal Bank of Canada’s price objective would suggest a potential downside of 2.13% from the stock’s previous close. A number of other equities analysts have also recently issued reports on NSC. ValuEngine upgraded shares of Norfolk Southern from a “hold” rating to a “buy” rating in a research report on Tuesday, February 12th. Zacks Investment Research upgraded shares of Norfolk Southern from a “hold” rating to a “buy” rating and set a $191.00 price objective on the stock in a research report on Wednesday, November 21st. Credit Suisse Group boosted their price objective on shares of Norfolk Southern from $181.00 to $195.00 and gave the company an “outperform” rating in a research report on Tuesday, February 12th. Loop Capital boosted their price objective on shares of Norfolk Southern to $210.00 and gave the company a “buy” rating in a research report on Monday, February 11th. Finally, BMO Capital Markets boosted their price objective on shares of Norfolk Southern to $185.00 and gave the company a “market perform” rating in a research report on Tuesday, February 12th. Two investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and twelve have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $183.62. Read more …

April 7, 2018

Notable Analyst Upgrades and Downgrades for Week of April 2, 2018


Upgrades:


Automatic Data Processing (NASDAQ:ADP) was upgraded by stock analysts at Royal Bank of Canada from a “sector perform” rating to an “outperform” rating in a note issued to investors on Monday, The Fly reports. The analysts noted that the move was a valuation call. Several other equities analysts also recently commented on the company. Bank of America upgraded Automatic Data Processing from a “neutral” rating to a “buy” rating in a report on Tuesday, December 5th. Goldman Sachs upgraded Automatic Data Processing from a “neutral” rating to a “buy” rating and increased their price target for the company from $116.02 to $135.00 in a report on Monday, December 11th. Zacks Investment Research upgraded Automatic Data Processing from a “hold” rating to a “buy” rating and set a $133.00 price target on the stock in a report on Monday, February 5th. BidaskClub upgraded Automatic Data Processing from a “sell” rating to a “hold” rating in a report on Wednesday, January 24th. Finally, Citigroup reiterated a “neutral” rating and set a $118.00 price target (up previously from $110.00) on shares of Automatic Data Processing in a report on Friday, January 12th. Ten equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $118.43. Read more …

Cardinal Health (NYSE:CAH) was upgraded by equities researchers at Argus from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday. The firm currently has a $85.00 price objective on the stock. Argus’ price target would indicate a potential upside of 35.61% from the company’s current price. CAH has been the subject of several other research reports. TheStreet raised shares of Cardinal Health from a “c+” rating to a “b-” rating in a research note on Tuesday, March 13th. Zacks Investment Research raised shares of Cardinal Health from a “hold” rating to a “buy” rating and set a $84.00 price target for the company in a research note on Monday, January 29th. Barclays began coverage on shares of Cardinal Health in a research note on Thursday, March 8th. They issued an “equal weight” rating and a $74.00 price target for the company. Jefferies Group set a $72.00 price target on shares of Cardinal Health and gave the company a “hold” rating in a research note on Friday, February 9th. Finally, Royal Bank of Canada set a $83.00 price target on shares of Cardinal Health and gave the company a “hold” rating in a research note on Thursday, February 8th. Three research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have issued a buy rating to the company. Cardinal Health currently has a consensus rating of “Hold” and a consensus target price of $75.46. Read more …

Darden Restaurants (NYSE:DRI) was upgraded by investment analysts at Royal Bank of Canada from a “sector perform” rating to an “outperform” rating in a report issued on Monday, Marketbeat reports. The brokerage presently has a $97.00 target price on the restaurant operator’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 14.45% from the company’s previous close. DRI has been the subject of a number of other reports. BMO Capital Markets cut their price objective on shares of Darden Restaurants from $99.00 to $97.00 and set a “market perform” rating for the company in a report on Thursday, March 22nd. SunTrust Banks reaffirmed a “hold” rating on shares of Darden Restaurants in a report on Thursday, December 21st. Zacks Investment Research lowered shares of Darden Restaurants from a “buy” rating to a “hold” rating in a report on Tuesday, March 6th. Wells Fargo reaffirmed a “market perform” rating and set a $99.00 price objective (up from $92.00) on shares of Darden Restaurants in a report on Tuesday, January 9th. Finally, Barclays reiterated an “overweight” rating and set a $116.00 target price (up from $108.00) on shares of Darden Restaurants in a research report on Tuesday, January 16th. One research analyst has rated the stock with a sell rating, thirteen have issued a hold rating and fourteen have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $98.26. Read more …


Union Pacific (NYSE:UNP) was upgraded by research analysts at Deutsche Bank from a “hold” rating to a “buy” rating in a report released on Monday. The brokerage currently has a $158.00 price target on the railroad operator’s stock. Deutsche Bank’s target price would suggest a potential upside of 17.58% from the stock’s current price. A number of other equities analysts also recently issued reports on the company. UBS upgraded Union Pacific from a “neutral” rating to a “buy” rating in a research note on Friday, January 5th. BMO Capital Markets restated a “buy” rating and issued a $150.00 price target on shares of Union Pacific in a research note on Monday, January 8th. Citigroup upgraded Union Pacific from a “neutral” rating to a “buy” rating in a research note on Wednesday, February 14th. Zacks Investment Research upgraded Union Pacific from a “hold” rating to a “buy” rating and set a $157.00 price target on the stock in a research note on Monday, January 15th. Finally, Wolfe Research upgraded Union Pacific from a “market perform” rating to an “outperform” rating in a research note on Friday, January 5th. Three investment analysts have rated the stock with a sell rating, twelve have assigned a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $136.10. Read more …